Moreover, CRP, ferritin, IL-6, IP-10, and SAA1/A2 did not show any significant differences in serum samples at hospital admission of COVID-19 patients who had already received anti-inflammatory treatment before the first sample collection compared to those who had not received any treatment yet (Figure S4). The gene discussed is CXCL10; the disease is COVID-19.